Cyproterone - direct healthcare professional communication (DHPC)

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Restrictions in use of cyproterone acetate due to risk of meningioma

Key facts

• Active substance:
  cyproterone
• Therapeutic area (MeSH):
  Androgen Antagonists
• Procedure number:
  EMEA/H/A-31/1488
• Regulatory outcome:
  Variation
• DHPC type:
  Referral - Article 31